Local de publicação venue para
- Relevance of Macrophage Extracellular Traps in C. albicans Killing 2019
- Thymic Function As a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy 2019
- Lipoarabinomannan in Active and Passive Protection Against Tuberculosis 2019
- PTX3 Polymorphisms Influence Cytomegalovirus Reactivation After Stem-Cell Transplantation 2019
- The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis 2018
- The Troika Host–Pathogen–Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes 2018
- Extracellular purine metabolism is the Switchboard of immunosuppressive macrophages and a novel target to treat diseases with macrophage imbalances 2018
- Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model 2018
- CD4 T follicular helper cells and HIV infection: Friends or enemies? 2017
- The absence of NOD1 enhances killing of Aspergillus fumigatus through modulation of dectin-1 expression 2017
- Interleukin-27 early impacts Leishmania infantum infection in mice and correlates with active visceral disease in humans 2016
- IL-17A Promotes Intracellular Growth of Mycobacterium by Inhibiting Apoptosis of Infected Macrophages 2015
- DAMP signaling in fungal infections and diseases 2012
- Immunity and tolerance to fungi in hematopoietic transplantation: Principles and perspectives 2012
- Neutrophils and macrophages: The main partners of phagocyte cell systems 2012
- The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol. 15. 2024
- The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol 2024
- Serum amyloid A proteins reduce bone mass during mycobacterial infections. 14. 2023
- Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets. 2023
- Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids. 13. 2022
- A cytokine/PTX3 prognostic index as a predictor of mortality in sepsis. 13. 2022
- IL-10 Overexpression After BCG Vaccination Does Not Impair Control of Mycobacterium tuberculosis Infection.. 13:946181. 2022
- Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis. 13. 2022
- IFNg and iNOS-Mediated Alterations in the Bone Marrow and Thymus and Its Impact on Mycobacterium avium-Induced Thymic Atrophy. 12. 2021
- IFNg and iNOS-Mediated Alterations in the Bone Marrow and Thymus and Its Impact on Mycobacterium avium-Induced Thymic Atrophy. 12. 2021
- High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids. 12. 2021
- High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids. 12. 2021
- Enhanced Glycolysis Is Required for Antileishmanial Functions of Neutrophils Upon Infection With Leishmania donovani. 12. 2021
- Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia. 12:263. 2021
- Changes in the Immune Phenotype and Gene Expression Profile Driven by a Novel Tuberculosis Nanovaccine: Short and Long-Term Post-immunization. 11. 2021
- Current Challenges for IDO2 as Target in Cancer Immunotherapy. 12:679953. 2021
- Editorial: Mycobacterial Glycolipids—Role in Immunomodulation and Targets for Vaccine Development. 11. 2020
- Cognition Is Associated With Peripheral Immune Molecules in Healthy Older Adults: A Cross-Sectional Study. 11. 2020
- Editorial: Host and Pathogen Determinants of Allergic and Invasive Fungal Diseases. 11:856. 2020
- Lipoarabinomannan in Active and Passive Protection Against Tuberculosis. 10:1968. 2019
- Thymic Function as a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy. 10:25. 2019
- The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review. 9. 2018